Literature DB >> 2166278

Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes.

A Balasubramaniam1, S Sheriff, D F Rigel, J E Fischer.   

Abstract

Neuropeptide Y (NPY) binding sites in rat cardiac ventricular membranes have been characterized in detail. 125I-NPY bound to the membranes with high affinity. Binding was saturable, reversible and specific, and depended on time, pH and temperature. Analysis of the binding data obtained under optimal conditions, 2 hr, 18 degrees C and at pH 7.5, revealed the presence of low and high affinity binding sites. The high affinity binding sites had an apparent dissociation constant (Kd) of 0.38 nM and a binding capacity (Bmax) of 7.13 fmol/mg protein. The apparent Kd and Bmax for low affinity binding sites were 22.34 nM and 261.25 fmol/mg protein, respectively. Peptides unrelated to NPY did not compete with 125I-NPY for the binding sites even at 1 microM concentrations, whereas homologous peptides, peptide YY (PYY) and pancreatic polypeptide (PP), and NPY(13-36) inhibited 125I-NPY binding but with lower potency compared to NPY. 125I-NPY binding was sensitive to the nonhydrolyzable GTP analog, Gpp(NH)p, suggesting that the NPY receptor is coupled to the adenylate cyclase system. The ventricular membrane receptor characterized in this study may play an important role in mediating the physiological effects of NPY in the heart.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166278     DOI: 10.1016/0196-9781(90)90057-c

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.

Authors:  A P Serone; J A Angus
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.

Authors:  M P Heredia; M Fernández-Velasco; G Benito; C Delgado
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

3.  Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.

Authors:  S Palea; M Corsi; J M Rimland; D G Trist
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

4.  Effects of neuropeptide Y on L-type calcium current in guinea-pig ventricular myocytes.

Authors:  S M Bryant; G Hart
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  Effects of phosphorothioated neuropeptide Y Y1-receptor antisense oligodeoxynucleotide in conscious rats and in human vessels.

Authors:  X Y Sun; X H Zhao; D Erlinge; L Edvinsson; B Fallgren; C Wahlestedt; T Hedner
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

6.  Neuropeptide Y and the development of cancer anorexia.

Authors:  W T Chance; A Balasubramaniam; J E Fischer
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.